Reposted from WuXi STA

(2023年)

Do you have an oligonucleotide, peptide, or related conjugate in your pipeline? WuXi STA has built comprehensive CRDMO platforms for these modalities. We have the expertise and state-of-the-art facilities across seven sites to support your every need from drug discovery to commercial manufacturing. Meet us in Boston this May at TIDES USA booth #618 to learn how we can help accelerate your programs.
Email STA_Info@wuxiapptec.com to schedule a meeting to discuss how we can accelerate your therapy.
Learn more about our comprehensive oligohttps://peptide.wuxiapptec.com/

コメント